JAMA Cardiology
Original Investigation
February 21, 2024
Michael T.ÌýLu, MD, MPH; Heather Ribaudo, PhD; Borek Foldyna, MD; Markella V.ÌýZanni, MD; Thomas Mayrhofer, PhD; Julia Karady, MD, PhD; Jana Taron, MD; Kathleen V.ÌýFitch, MSN; Sara McCallum, MPH; Tricia H.ÌýBurdo, PhD; Kayla Paradis, MBA; Sandeep S.ÌýHedgire, MD; Nandini M.ÌýMeyersohn, MD; Christopher DeFilippi, MD; Carlos D.ÌýMalvestutto, MD, MPH; Audra Sturniolo, MS; Marissa Diggs, BA; Sue Siminski, MBA; Gerald S.ÌýBloomfield, MD; Beverly Alston-Smith, MD; Patrice Desvigne-Nickens, MD; Edgar T.ÌýOverton, MD; Judith S.ÌýCurrier, MD; Judith A.ÌýAberg, MD; Carl J.ÌýFichtenbaum, MD; Udo Hoffmann, MD, MPH; Pamela S.ÌýDouglas, MD; Steven K.ÌýGrinspoon, MD; REPRIEVE Trial Writing Group
open access
has multimedia
JAMA Cardiol. 2024; 9(4):323-334. 10.1001/jamacardio.2023.5661
This substudy of a randomized clinical trial investigates the effects of pitavastatin on noncalcified coronary artery plaque using coronary computed tomography angiography and on inflammatory biomarkers as potential mechanisms for major adverse cardiovascular event prevention.
JAMA Cardiology
Original Investigation
February 1, 2018
Maros Ferencik, MD, PhD, MCR; Thomas Mayrhofer, PhD; Daniel O.ÌýBittner, MD; Hamed Emami, MD; Stefan B.ÌýPuchner, MD; Michael T.ÌýLu, MD, MPH; Nandini M.ÌýMeyersohn, MD; Alexander V.ÌýIvanov, BS; Elizabeth C.ÌýAdami, BS; Manesh R.ÌýPatel, MD; Daniel B.ÌýMark, MD, MPH; James E.ÌýUdelson, MD; Kerry L.ÌýLee, PhD; Pamela S.ÌýDouglas, MD; Udo Hoffmann, MD, MPH
free access
JAMA Cardiol. 2018; 3(2):144-152. 10.1001/jamacardio.2017.4973
This nested observational cohort study seeks to determine whether high-risk plaque detected by coronary computed tomographic angiography was independently associated with major adverse cardiovascular events.